Literature DB >> 3410462

Human apolipoprotein A-IV polymorphism: frequency and effect on lipid and lipoprotein levels.

H J Menzel1, E Boerwinkle, S Schrangl-Will, G Utermann.   

Abstract

Human apolipoprotein (apo) A-IV is genetically polymorphic, the apo A-IV polymorphism being controlled by two common alleles, A-IV1 and A-IV2. We have developed a method for typing the apo A-IV polymorphism by Western blotting using polyclonal rabbit antiapo A-IV as the first and gold-labeled antirabbit IgG as the second antibody. Apolipoprotein phenotypes were determined in plasma samples from 473 tiroleans. The frequencies of the apo A-IV alleles in this sample were f(A-IV1) = 0.919, f(A-IV2) = 0.077, and f(A-IV3) = 0.004. Although average triglyceride levels were lower in apo A-IV 2-1 heterozygotes, average total serum cholesterol and triglyceride levels were not significantly different among apo A-IV types. High density lipoprotein (HDL) cholesterol was significantly increased in individuals with the A-IV 2-1 phenotype. We estimate that genetic variation at the apo A-IV gene locus accounts for 11% of the total variability in HDL-cholesterol levels in Tiroleans. The effects of the apo A-IV polymorphism described here are consistant with, and may serve to enrich, our limited knowledge of the role of apo A-IV in lipid metabolism.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3410462     DOI: 10.1007/bf00282179

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  22 in total

1.  Isolation and characterization of an apoprotein from the d less than 1.006 lipoproteins of human and canine lymph homologous with the rat A-IV apoprotein.

Authors:  K H Weisgraber; T P Bersot; R W Mahley
Journal:  Biochem Biophys Res Commun       Date:  1978-11-14       Impact factor: 3.575

2.  Bias of the contribution of single-locus effects to the variance of a quantitative trait.

Authors:  E Boerwinkle; C F Sing
Journal:  Am J Hum Genet       Date:  1986-07       Impact factor: 11.025

3.  Genetic studies of human apolipoproteins. I. Polymorphism of apolipoprotein A-IV.

Authors:  M I Kamboh; R E Ferrell
Journal:  Am J Hum Genet       Date:  1987-08       Impact factor: 11.025

4.  Immunohistochemical localization of barley stripe mosaic virions in infected wheat cells.

Authors:  N S Lin; W G Langenberg
Journal:  J Ultrastruct Res       Date:  1983-07

5.  Human intestinal lipoproteins. Studies in chyluric subjects.

Authors:  P H Green; R M Glickman; C D Saudek; C B Blum; A R Tall
Journal:  J Clin Invest       Date:  1979-07       Impact factor: 14.808

6.  A method to screen apolipoprotein polymorphisms in whole plasma: description of apolipoprotein A-IV variants in dyslipidemias and a reassessment of apolipoprotein A-I in Tangier disease.

Authors:  C L Bisgaier; E S Lee; R M Glickman
Journal:  Biochim Biophys Acta       Date:  1987-04-24

7.  Characterization of human very low density lipoproteins containing two electrophoretic populations: double pre-beta lipoproteinemia and primary dysbetalipoproteinemia.

Authors:  A Pagnan; R J Havel; J P Kane; L Kotite
Journal:  J Lipid Res       Date:  1977-09       Impact factor: 5.922

8.  Apolipoprotein A-IV polymorphism in man.

Authors:  H J Menzel; P M Kövary; G Assmann
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

9.  One-step screening method for the polymorphism of apolipoproteins A-I, A-II, and A-IV.

Authors:  H J Menzel; R G Kladetzky; G Assmann
Journal:  J Lipid Res       Date:  1982-08       Impact factor: 5.922

10.  Distribution of apolipoprotein A-IV in human plasma.

Authors:  C L Bisgaier; O P Sachdev; L Megna; R M Glickman
Journal:  J Lipid Res       Date:  1985-01       Impact factor: 5.922

View more
  8 in total

1.  Changes of genetic apolipoprotein phenotypes caused by liver transplantation. Implications for apolipoprotein synthesis.

Authors:  H G Kraft; H J Menzel; F Hoppichler; W Vogel; G Utermann
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

2.  Apolipoprotein C-III(Lys58----Glu). Identification of an apolipoprotein C-III variant in a family with hyperalphalipoproteinemia.

Authors:  A von Eckardstein; H Holz; M Sandkamp; W Weng; H Funke; G Assmann
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

3.  Minor allele of the APOA4 gene T347S polymorphism predisposes to obesity in postmenopausal Turkish women.

Authors:  Filiz Guclu-Geyik; Altan Onat; Neslihan Coban; Evrim Komurcu-Bayrak; Vedat Sansoy; Günay Can; Nihan Erginel-Unaltuna
Journal:  Mol Biol Rep       Date:  2012-10-25       Impact factor: 2.316

4.  Rapid in vivo transport and catabolism of human apolipoprotein A-IV-1 and slower catabolism of the apoA-IV-2 isoprotein.

Authors:  D J Rader; J Schäfer; P Lohse; B Verges; M Kindt; L A Zech; A Steinmetz; H B Brewer
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

5.  Nonsynonymous polymorphic sites in the apolipoprotein (apo) A-IV gene are associated with changes in the concentration of apo B- and apo A-I-containing lipoproteins in a normal population.

Authors:  A von Eckardstein; H Funke; M Schulte; M Erren; H Schulte; G Assmann
Journal:  Am J Hum Genet       Date:  1992-05       Impact factor: 11.025

6.  Frequency and effect of human apolipoprotein A-IV polymorphism on lipid and lipoprotein levels in an Icelandic population.

Authors:  H J Menzel; G Sigurdsson; E Boerwinkle; S Schrangl-Will; H Dieplinger; G Utermann
Journal:  Hum Genet       Date:  1990-03       Impact factor: 4.132

7.  Apolipoprotein A-IV protein polymorphism: frequency and effects on lipids, lipoproteins, and apolipoproteins among Mexican-Americans in Starr County, Texas.

Authors:  C L Hanis; T C Douglas; D Hewett-Emmett
Journal:  Hum Genet       Date:  1991-01       Impact factor: 4.132

8.  Polymorphisms in the apolipoprotein (apo) AI-CIII-AIV gene cluster: detection of genetic variation determining plasma apo AI, apo CIII and apo AIV concentrations.

Authors:  H Paul-Hayase; M Rosseneu; D Robinson; J P Van Bervliet; J P Deslypere; S E Humphries
Journal:  Hum Genet       Date:  1992-02       Impact factor: 4.132

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.